291 related articles for article (PubMed ID: 19086957)
21. Percutaneous thermal ablation of medium and large hepatocellular carcinoma: long-term outcome and prognostic factors.
Yin XY; Xie XY; Lu MD; Xu HX; Xu ZF; Kuang M; Liu GJ; Liang JY; Lau WY
Cancer; 2009 May; 115(9):1914-23. PubMed ID: 19241423
[TBL] [Abstract][Full Text] [Related]
22. Radiofrequency ablation with hand-assisted laparoscopic surgery for the treatment of hepatocellular carcinoma in the caudate lobe.
Ishiko T; Beppu T; Sugiyama S; Masuda T; Takahashi M; Komori H; Takamori H; Hirota M; Kanemitu K; Baba H
Surg Laparosc Endosc Percutan Tech; 2008 Jun; 18(3):272-6. PubMed ID: 18574414
[TBL] [Abstract][Full Text] [Related]
23. Tolerance of radiofrequency ablation by patients of hepatocellular carcinoma.
Cheung TT; Ng KK; Poon RT; Fan ST
J Hepatobiliary Pancreat Surg; 2009; 16(5):655-60. PubMed ID: 19370304
[TBL] [Abstract][Full Text] [Related]
24. Serum alpha-fetoprotein response can predict prognosis in hepatocellular carcinoma patients undergoing radiofrequency ablation therapy.
Kao WY; Chiou YY; Hung HH; Su CW; Chou YH; Wu JC; Huo TI; Huang YH; Wu WC; Lin HC; Lee SD
Clin Radiol; 2012 May; 67(5):429-36. PubMed ID: 22153231
[TBL] [Abstract][Full Text] [Related]
25. Intrahepatic recurrence after percutaneous radiofrequency ablation of hepatocellular carcinoma: analysis of the pattern and risk factors.
Kim YS; Rhim H; Cho OK; Koh BH; Kim Y
Eur J Radiol; 2006 Sep; 59(3):432-41. PubMed ID: 16690240
[TBL] [Abstract][Full Text] [Related]
26. [Effectiveness of radiofrequency ablation combined with transcatheter arterial chemoembolization for hepatocellular carcinoma].
Gao HJ; Liang HH; Chen MS; Peng ZW; Zhang YJ; Li P; Pang XH; Zhang YQ; Li JQ
Zhonghua Yi Xue Za Zhi; 2008 Sep; 88(36):2529-32. PubMed ID: 19080642
[TBL] [Abstract][Full Text] [Related]
27. Incomplete ablation after radiofrequency ablation of hepatocellular carcinoma: analysis of risk factors and prognostic factors.
Lam VW; Ng KK; Chok KS; Cheung TT; Yuen J; Tung H; Tso WK; Fan ST; Poon RT
Ann Surg Oncol; 2008 Mar; 15(3):782-90. PubMed ID: 18095030
[TBL] [Abstract][Full Text] [Related]
28. Clinical characteristics among patients with hepatocellular carcinoma according to the serum levels of alpha-fetoprotein and des-y-carboxy prothrombin.
Dohmen K; Shigematsu H; Irie K; Ishibashi H
Hepatogastroenterology; 2003; 50(54):2072-8. PubMed ID: 14696467
[TBL] [Abstract][Full Text] [Related]
29. Significance of alpha-fetoprotein and des-gamma-carboxy prothrombin in patients with hepatocellular carcinoma undergoing hepatectomy.
Yamamoto K; Imamura H; Matsuyama Y; Hasegawa K; Beck Y; Sugawara Y; Makuuchi M; Kokudo N
Ann Surg Oncol; 2009 Oct; 16(10):2795-804. PubMed ID: 19669841
[TBL] [Abstract][Full Text] [Related]
30. Predictive factors for distant recurrence of HCV-related hepatocellular carcinoma after radiofrequency ablation combined with chemoembolization.
Fuke H; Sugimoto K; Shiraki K; Tanaka J; Beppu T; Yoneda K; Yamamoto N; Ito K; Takaki H; Nakatsuka A; Yamakado K; Takeda K; Takei Y
Aliment Pharmacol Ther; 2008 Jun; 27(12):1253-60. PubMed ID: 18221404
[TBL] [Abstract][Full Text] [Related]
31. Impact of radiofrequency ablation on the management of patients with hepatocellular carcinoma in a specialized centre.
Lam CM; Ng KK; Poon RT; Ai V; Yuen J; Fan ST
Br J Surg; 2004 Mar; 91(3):334-8. PubMed ID: 14991635
[TBL] [Abstract][Full Text] [Related]
32. Comparison of seven staging systems in cirrhotic patients with hepatocellular carcinoma in a cohort of patients who underwent radiofrequency ablation with complete response.
Guglielmi A; Ruzzenente A; Pachera S; Valdegamberi A; Sandri M; D'Onofrio M; Iacono C
Am J Gastroenterol; 2008 Mar; 103(3):597-604. PubMed ID: 17970836
[TBL] [Abstract][Full Text] [Related]
33. Seeding risk following percutaneous approach to hepatocellular carcinoma.
Perkins JD
Liver Transpl; 2007 Nov; 13(11):1603. PubMed ID: 17969186
[TBL] [Abstract][Full Text] [Related]
34. Surgical resection versus radiofrequency ablation for small hepatocellular carcinomas within the Milan criteria.
Ueno S; Sakoda M; Kubo F; Hiwatashi K; Tateno T; Baba Y; Hasegawa S; Tsubouchi H;
J Hepatobiliary Pancreat Surg; 2009; 16(3):359-66. PubMed ID: 19300896
[TBL] [Abstract][Full Text] [Related]
35. Repeat radiofrequency ablation provides survival benefit in patients with intrahepatic distant recurrence of hepatocellular carcinoma.
Okuwaki Y; Nakazawa T; Kokubu S; Hidaka H; Tanaka Y; Takada J; Watanabe M; Shibuya A; Minamino T; Saigenji K
Am J Gastroenterol; 2009 Nov; 104(11):2747-53. PubMed ID: 19603009
[TBL] [Abstract][Full Text] [Related]
36. Irregular vascular pattern by contrast-enhanced ultrasonography and high serum Lens culinaris agglutinin-reactive fraction of alpha-fetoprotein level predict poor outcome after successful radiofrequency ablation in patients with early-stage hepatocellular carcinoma.
Takada H; Tsuchiya K; Yasui Y; Nakakuki N; Tamaki N; Suzuki S; Nakanishi H; Itakura J; Takahashi Y; Kurosaki M; Asahina Y; Enomoto N; Izumi N
Cancer Med; 2016 Nov; 5(11):3111-3120. PubMed ID: 27748052
[TBL] [Abstract][Full Text] [Related]
37. Radiofrequency ablation versus percutaneous microwave coagulation therapy for small hepatocellular carcinomas: a retrospective comparative study.
Ohmoto K; Yoshioka N; Tomiyama Y; Shibata N; Kawase T; Yoshida K; Kuboki M; Yamamoto S
Hepatogastroenterology; 2007 Jun; 54(76):985-9. PubMed ID: 17629022
[TBL] [Abstract][Full Text] [Related]
38. Relationship between Lens culinaris agglutinin-reactive alpha-fetoprotein and pathologic features of hepatocellular carcinoma.
Tada T; Kumada T; Toyoda H; Kiriyama S; Sone Y; Tanikawa M; Hisanaga Y; Kitabatake S; Kuzuya T; Nonogaki K; Shimizu J; Yamaguchi A; Isogai M; Kaneoka Y; Washizu J; Satomura S
Liver Int; 2005 Aug; 25(4):848-53. PubMed ID: 15998436
[TBL] [Abstract][Full Text] [Related]
39. Comparison of therapeutic effects between radiofrequency ablation and percutaneous microwave coagulation therapy for small hepatocellular carcinomas.
Ohmoto K; Yoshioka N; Tomiyama Y; Shibata N; Kawase T; Yoshida K; Kuboki M; Yamamoto S
J Gastroenterol Hepatol; 2009 Feb; 24(2):223-7. PubMed ID: 18823439
[TBL] [Abstract][Full Text] [Related]
40. Comparison of percutaneous and surgical approaches for radiofrequency ablation of small and medium hepatocellular carcinoma.
Khan MR; Poon RT; Ng KK; Chan AC; Yuen J; Tung H; Tsang J; Fan ST
Arch Surg; 2007 Dec; 142(12):1136-43; discussion 1143. PubMed ID: 18086979
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
